Its strange really because it seems that officially the genentech extension is purely only regsrding the microbials and nothing to do with oncology or myc. At this point in time officially we still have no interested parties in myc side of things. Would have thought the recent foubling of shate price eas about more than just genentech interest in their original deal? It would certainly shake things up if a new deal or collaboration was announced in the myc research with a commercial company rather than a research body.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.020(1.56%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.29 | $1.25 | $4.616M | 3.649M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19940 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 1008 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |